Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical.

Similar presentations


Presentation on theme: "Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical."— Presentation transcript:

1 Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group*  David RW Jayne, M.D., Niels Rasmussen, M.D.  Mayo Clinic Proceedings  Volume 72, Issue 8, Pages (August 1997) DOI: /S (11) Copyright © 1997 Mayo Foundation for Medical Education and Research Terms and Conditions

2 Fig. 1 Objectives of the collaborative European systemic vasculitis clinical trials project. ANCA = antineutrophil cytoplasm autoantibodies. Mayo Clinic Proceedings  , DOI: ( /S (11) ) Copyright © 1997 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical."

Similar presentations


Ads by Google